N19-0881
N19-0881 (Compound 33) is an orally active, potent and selective KDM5A/5B histone lysine demethylase inhibitor (IC50= 0.013 μM and 0.002 μM, respectively) . N19-0881 is promising for research of epigenetically dysregulated tumors (e.g., breast cancer) [1].
Product Specifications
CAS Number
1613410-75-5
UNSPSC
12352005
Target
Histone Demethylase
Related Pathways
Epigenetics
Field of Research
Cancer
Smiles
O=C(C1=CC(N2N=CC=C2OCC3=CC=C(Cl)C=C3C)=NC=C1)O
Molecular Formula
C17H14ClN3O3
Molecular Weight
343.76
References & Citations
[1]Nie Z, et al. Structure-based design and discovery of potent and selective KDM5 inhibitors. Bioorg Med Chem Lett. 2018 May 15;28 (9) :1490-1494.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
KDM5
More Discoveries
Explore Other Products
Browse additional items from our catalog
31444114 3x 1.0 µg
Nap1l4 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)
Sign In for Pricing
View Details 
K0037704 1.0 µg DNA
ACTL9 sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
MBS1271668-01 0.01 mg Plasmid + 0.2 mL Glycerol-Stock
ARSF cDNA Clone
Sign In for Pricing
View Details 
MBS1271668-02 5x 0.01 mg Plasmid + 5x 0.2 mL Glycerol-Stock
ARSF cDNA Clone
Sign In for Pricing
View Details